Realcan Pharmaceutical Group Co., Ltd. (SHE:002589)
3.270
-0.020 (-0.61%)
At close: Feb 13, 2026
SHE:002589 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 4,241 | 4,984 | 5,061 | 5,340 | 4,579 | 5,753 |
Trading Asset Securities | - | - | - | - | - | 40.79 |
Cash & Short-Term Investments | 4,241 | 4,984 | 5,061 | 5,340 | 4,579 | 5,794 |
Cash Growth | -9.53% | -1.52% | -5.23% | 16.63% | -20.97% | 13.77% |
Accounts Receivable | 4,383 | 4,375 | 4,222 | 4,603 | 11,276 | 15,183 |
Other Receivables | 944.69 | 892.75 | 990.01 | 1,670 | 1,897 | 1,429 |
Receivables | 5,328 | 5,268 | 5,212 | 6,274 | 13,172 | 16,611 |
Inventory | 692.93 | 734.74 | 1,119 | 954.51 | 2,068 | 2,938 |
Prepaid Expenses | - | 0 | 0.11 | - | 7.27 | 0.9 |
Other Current Assets | 181.03 | 94.88 | 147.07 | 250.97 | 845.88 | 1,217 |
Total Current Assets | 10,443 | 11,081 | 11,539 | 12,820 | 20,672 | 26,561 |
Property, Plant & Equipment | 2,037 | 2,238 | 2,277 | 2,297 | 2,527 | 3,189 |
Long-Term Investments | 743.31 | 746.72 | 852.03 | 594.07 | 805.82 | 777.68 |
Goodwill | 146.67 | 146.67 | 146.67 | 146.69 | 620.27 | 804.51 |
Other Intangible Assets | 519.55 | 440.89 | 552.39 | 624.21 | 478.35 | 319.63 |
Long-Term Accounts Receivable | - | - | - | - | 0.07 | 0.87 |
Long-Term Deferred Tax Assets | 303.52 | 286.15 | 284.44 | 106.68 | 122.86 | 92.43 |
Long-Term Deferred Charges | 51.88 | 39.16 | 60.87 | 89.93 | 134.58 | 148.71 |
Other Long-Term Assets | 1,084 | 1,033 | 996.39 | 1,654 | 1,035 | 243.91 |
Total Assets | 15,329 | 16,012 | 16,709 | 18,332 | 26,397 | 32,137 |
Accounts Payable | 3,462 | 3,382 | 3,723 | 7,715 | 9,791 | 8,274 |
Accrued Expenses | 18.07 | 42.21 | 66.98 | 57.68 | 227.5 | 472.3 |
Short-Term Debt | 5,376 | 6,092 | 6,556 | 3,926 | 4,440 | 10,055 |
Current Portion of Long-Term Debt | 27.53 | 155.38 | 5.6 | 6.51 | 6.3 | - |
Current Portion of Leases | - | 0.76 | 0.52 | 1.82 | 10.09 | 1.2 |
Current Income Taxes Payable | 29.42 | 3.62 | 1.68 | 5 | 91.82 | 154.62 |
Current Unearned Revenue | 12.42 | 25.13 | 29.12 | 32.43 | 174.72 | 233.92 |
Other Current Liabilities | 472.66 | 232.26 | 378.53 | 724.46 | 1,766 | 1,977 |
Total Current Liabilities | 9,398 | 9,933 | 10,761 | 12,468 | 16,508 | 21,168 |
Long-Term Debt | 425.4 | 327.08 | 261.27 | 67.2 | 48.5 | 8.36 |
Long-Term Leases | 2.61 | 4.12 | 0.84 | 2.73 | 39.19 | - |
Long-Term Unearned Revenue | 4.71 | 4.74 | 1.62 | 1.93 | 17.5 | 18.88 |
Long-Term Deferred Tax Liabilities | 44.02 | 48.5 | 47.48 | 40.58 | 83.56 | 181.34 |
Other Long-Term Liabilities | - | - | - | - | 7.28 | 245.62 |
Total Liabilities | 9,875 | 10,318 | 11,072 | 12,581 | 16,704 | 21,622 |
Common Stock | 1,505 | 1,505 | 1,505 | 1,505 | 1,505 | 1,505 |
Additional Paid-In Capital | 3,483 | 3,589 | 3,720 | 3,701 | 4,015 | 4,020 |
Retained Earnings | 421.58 | 444.35 | 453.83 | 432.66 | 2,278 | 2,175 |
Treasury Stock | -60.39 | - | -230.65 | -230.65 | -230.65 | -230.65 |
Total Common Equity | 5,349 | 5,538 | 5,448 | 5,407 | 7,567 | 7,469 |
Minority Interest | 105.21 | 156.83 | 189.18 | 344 | 2,126 | 3,046 |
Shareholders' Equity | 5,454 | 5,695 | 5,637 | 5,751 | 9,693 | 10,515 |
Total Liabilities & Equity | 15,329 | 16,012 | 16,709 | 18,332 | 26,397 | 32,137 |
Total Debt | 5,831 | 6,579 | 6,824 | 4,004 | 4,544 | 10,064 |
Net Cash (Debt) | -1,590 | -1,595 | -1,764 | 1,336 | 34.82 | -4,271 |
Net Cash Growth | - | - | - | 3737.34% | - | - |
Net Cash Per Share | -1.06 | -1.06 | -1.17 | 0.90 | 0.02 | -2.94 |
Filing Date Shares Outstanding | 1,484 | 1,505 | 1,496 | 1,496 | 1,496 | 1,496 |
Total Common Shares Outstanding | 1,484 | 1,505 | 1,496 | 1,496 | 1,496 | 1,496 |
Working Capital | 1,045 | 1,148 | 777.98 | 351.12 | 4,164 | 5,393 |
Book Value Per Share | 3.60 | 3.68 | 3.64 | 3.61 | 5.06 | 4.99 |
Tangible Book Value | 4,683 | 4,950 | 4,749 | 4,636 | 6,468 | 6,345 |
Tangible Book Value Per Share | 3.15 | 3.29 | 3.17 | 3.10 | 4.32 | 4.24 |
Buildings | - | 1,974 | 1,819 | 1,865 | 1,468 | 1,695 |
Machinery | - | 686.13 | 695.38 | 778.65 | 1,436 | 1,530 |
Construction In Progress | - | 307.34 | 429.34 | 315.37 | 549.58 | 870.89 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.